Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis

University of California San Francisco (UCSF)

Status

Conditions: Leishmaniasis, Mucocutaneous; Leishmaniasis, Cutaneous

Treatments: Drug: sodium stibogluconate (Pentostam)

Study type: Expanded Access

Funder types: Other

Identifiers

NCT00508963

UCSF Infectious Diseases

Details and patient eligibility

About

Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Biopsy proven new world cutaneous or mucocutaneous leishmania

Exclusion criteria

• Prolonged QT
• Liver disease
• Pancreatitis